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Centrosome NumbersAccurate control of centrosome number is critical for the maintenance of
genomic integrity. A recent study reveals that the deubiquitinating enzyme
USP33 regulates centrosome biogenesis by stabilizing the centriolar protein
CP110.Felix Ba¨renz and Ingrid Hoffmann*
The centrosome is a non-membrane-
bound organelle found in most animal
cells. It has several important
functions, including control of cilia
formation, microtubule organization
and nucleation, spindle assembly
and transport of organelles and
vesicles. Centrosomes consist of two
centrioles, which are barrel-shaped
microtubule-based structures
surrounded by an electron-dense
matrix, the pericentriolar material
(PCM). Duplication of centrioles must
occur in coordination with DNA
synthesis only once per cell cycle and
duplication involves the assembly of a
new daughter centriole (procentriole)
next to the proximal end of the mother
centriole [1]. In human cells, hSAS-6,
STIL, CEP135, CPAP, g-tubulin, and
CP110 have been identified as
essential factors required at the onset
of centriole biogenesis for centriole
formation [2,3]. The newly formed
procentrioles then start to elongate,
increase in length during S phase, and
are fully assembled in G2 phase of the
cell cycle. A new study by Li et al. [4]
now reports a role for deubiquitination
in the stabilization of CP110 during
S/G2 phase.
The protein CP110 was first
identified as a Cdk2 substrate required
for centrosome overduplication in
S-phase-arrested cells [5]. It is
associated with the growing centriolar
distal tips, forming a cap beneath
which centrioles elongate through the
insertion of a/b-tubulin [2]. Depletion of
CP110 or overexpression of CPAP was
shown to induce centriole elongation,
suggesting that CPAP and CP110 play
opposing roles in controlling centriolelength [6–8]. CP110 in a complex with
its regulator Cep97 also plays an
additional role in preventing cilia
formation through the inhibition of
centriole to basal body conversion [9].
CP110 protein levels are tightly
controlled during the cell cycle in order
to prevent centriole duplication errors.
CP110 physically associates with the
F-box protein cyclin F on centrioles
during the G2 phase of the cell cycle
and is then ubiquitinated by the
SCFCyclinF E3 ubiquitin ligase complex,
leading to its degradation [10]. The new
study by Li et al. [4] now reports that
deubiquitination is also an important
mechanism for the regulation of CP110
protein levels during the cell cycle.
Polyubiquitinated proteins that are
marked for degradation can be
stabilized in response to the activity
of deubiquitinating enzymes
(DUBs) — proteases that remove the
polyubiquitin chain. Around 100 active
DUBs are found in the human genome
[11] and, as a result of their ability to
reverse ubiquitination, these enzymes
control a broad range of key cellular
processes. Li et al. [4] report that
the DUB USP33 (ubiquitin-specific
protease 33, also known as VDU1)
binds to CP110 and specifically
deubiquitinates CP110 in a cell-cycle-
dependent manner, thus counteracting
SCFCyclinF ubiquitin ligase
activity (Figure 1).
Although several SCF ubiquitin ligase
complexes have been recently shown
to regulate centrosome biogenesis
[12], DUBs had not been demonstrated
to be involved in the regulation of this
process until now. Both USP33 and the
highly related USP20 (also known as
VDU2) interact with CP110, but USP33
has a greater impact on CP110 levelsthan USP20. USP33 and USP20 are
mainly localized to the cytoplasm, in
particular to the endoplasmic reticulum
[13]. USP33 additionally localizes to the
proximal end of centrioles, whereas
CP110 is a distal-end-capping protein,
suggesting that only a subpopulation of
CP110 interacts with USP33. USP33
localizes to centrosomes primarily
during S and G2 phase of the cell cycle
similar to CP110. Centriolar targeting
of USP33 is at least in part dependent
on CP110 because depletion of CP110
reduced USP33 localization to the
centrosome. USP33 specifically
deubiquitinates CP110 both in vitro and
in vivo. The amino-terminal domain of
CP110 interacts with the catalytic
domain of USP33 and is required for
USP33-mediated deubiquitination.
As CP110 is a crucial player in
centriole duplication, it is intriguing to
ask whether centriole duplication
would also be affected in the absence
of the CP110-stabilizing effects of
USP33. Li et al. [4] found that USP33
depletion did not inhibit normal
centriole duplication through loss of
centrioles: instead, loss of USP33
inhibited centrosome re-duplication. In
some cell lines, for example U2OS,
centrosome re-duplication can
be induced by the addition of
hydroxyurea, which promotes
cell-cycle arrest at the G1/S phase
transition but does not affect
centrosome duplication and thereby
results in an increase in centrosome
numbers. A similar effect on
centrosome duplication is caused by
CP110 depletion [5]. Intriguingly,
co-depletion of USP33 and SCFcyclinF
rescued the mitotic defects caused
upon siRNA-mediated downregulation
of SCFcyclinF [4]. Therefore, opposing
activities of E3 ubiquitin ligases and
DUBs that both target key regulators of
centriole duplication may represent a
general mechanism for regulating the
levels of those factors during the cell
cycle and centriole biogenesis.
Supernumerary centrosomes are
frequently found in cancer cells. During
cell division too many centrosomes
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Figure 1. Keeping CP110 levels under control.
The centriolar distal end protein CP110 is an essential player in centriole duplication by
controling the length of centrioles. (A) During S and G2 phases, at the time of centriole
elongation, CP110 localizes to centrioles and is released from the centrioles and finally
degraded during late G2/M phase. (B) CP110 protein levels are tightly regulated throughout
the cell cycle. To ensure proper centriole elongation, CP110 is stabilized during S/G2 phase
by USP33, a newly discovered deubiquitinating enzyme (DUB). At the end of G2 phase,
when centriole elongation is completed, CP110 is polyubiquitinated by the SCFCyclinF ubiquitin
ligase complex and subsequently degraded by the proteasome. It is likely that USP33 is also
degraded by the proteasome at the end of G2 phase.
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R460induce errors in chromosome
segregation and lead to aneuploidy as
a result of transient multipolar spindle
formation [14]. Interestingly, Li et al. [4]
also found that both USP33 and CP110
are upregulated and their protein levels
strongly correlated in a variety of
pancreatic tumor cell lines and
pancreatic cancer tissue samples.
CP110 is targeted for ubiquitinationand degradation during G2 phase by
SCFcyclinF and SCFcyclinF levels also
peak in G2. It would be interesting to
see whether SCFcyclinF levels correlate
with USP33 and CP110 levels in
pancreatic cancer cells.
This work therefore reveals that a
dynamic balance of ubiquitination by
SCFcyclinF and deubiquitination by
USP33 contributes to the onset ofcentriole duplication and elongation.
In the future, it will be important to
understand more about the roles of
different DUBs in the control of
other critical regulators of centriole
biogenesis and ciliogenesis and their
impact on the generation of aneuploidy.
References
1. Nigg, E.A., and Stearns, T. (2011). The
centrosome cycle: Centriole biogenesis,
duplication and inherent asymmetries. Nat.
Cell Biol. 3, 1154–1160.
2. Kleylein-Sohn, J., Westendorf, J., Le Clech, M.,
Habedanck, R., Stierhof, Y.D., and Nigg, E.A.
(2007). Plk4-induced centriole biogenesis in
human cells. Dev. Cell 13, 190–202.
3. Tang, C.J., Lin, S.Y., Hsu, W.B., Lin, Y.N.,
Wu, C.T., Lin, Y.C., Chang, C.W., Wu, K.S., and
Tang, T.K. (2011). The human microcephaly
protein STIL interacts with CPAP and is
required for procentriole formation. EMBO J.
30, 4790–4804.
4. Li, J., D’Angiolella, V., Seeley, E.S., Kim, S.,
Kobayashi, T., Fu, W., Campos, E.I.,
Pagano, M., and Dynlacht, B.D. (2013). USP33
regulates centrosome biogenesis via
deubiquitination of the centriolar protein
CP110. Nature 495, 255–259.
5. Chen, Z., Indjeian, V.B., McManus, M.,
Wang, L., and Dynlacht, B.D. (2002). CP110, a
cell cycle-dependent CDK substrate, regulates
centrosome duplication in human cells. Dev.
Cell 3, 339–350.
6. Kohlmaier, G., Loncarek, J., Meng, X.,
McEwen, B.F., Mogensen, M.M., Spektor, A.,
Dynlacht, B.D., Khodjakov, A., and Go¨nczy, P.
(2009). Overly long centrioles and defective cell
division upon excess of the SAS-4-related
protein CPAP. Curr. Biol. 23, 1012–1018.
7. Schmidt, T.I., Kleylein-Sohn, J., Westendorf, J.,
Le Clech, M., Lavoie, S.B., Stierhof, Y.D., and
Nigg, E.A. (2009). Control of centriole length by
CPAP and CP110. Curr. Biol. 12, 1005–1011.
8. Tang, C.J., Fu, R.H., Wu, K.S., Hsu, W.B., and
Tang, T.K. (2009). CPAP is a cell-cycle
regulated protein that controls centriole length.
Nat. Cell Biol. 11, 825–831.
9. Spektor, A., Tsang, W.Y., Khoo, D., and
Dynlacht, B.D. (2007). Cep97 and CP110
suppress a cilia assembly program. Cell 130,
678–690.
10. D’Angiolella, V., Donato, V., Vijayakumar, S.,
Saraf, A., Florens, L., Washburn, M.P.,
Dynlacht, B., and Pagano, M. (2010).
SCF(CyclinF) controls centrosome homeostasis
and mitotic fidelity through CP110 degradation.
Nature 466, 138–142.
11. Reyes-Turcu, F.E., Ventii, K.H., and
Wilkinson, K.D. (2009). Regulation and cellular
roles of ubiquitin-specific deubiquitinating
enzymes. Annu. Rev. Biochem. 78, 363–397.
12. Silverman, J.S., Skaar, J.R., and Pagano, M.
(2012). SCF ubiquitin ligases in the
maintenance of genome stability. Trends
Biochem. Sci. 37, 66–73.
13. Curcio-Morelli, C., Zavacki, A.M.,
Christofollete, M., Gereben, B., de Freitas, B.C.,
Harney, J.W., Li, Z., Wu, G., and Bianco, A.C.
(2003). Deubiquitination of type 2 iodothyronine
deiodinase by von Hippel-Lindau protein-
interacting deubiquitinating enzymes regulates
thyroid hormone activation. J. Clin. Invest. 112,
189–196.
14. Ganem, N.J., Godinho, S.A., and Pellman, D.
(2009). A mechanism linking extra centrosomes
tochromosomal instability.Nature460, 278–282.
Cell Cycle Control and Carcinogenesis, F045,
German Cancer Research Center, DKFZ,
Im Neuenheimer Feld 242, 69120 Heidelberg,
Germany.
*E-mail: Ingrid.Hoffmann@dkfz.de
http://dx.doi.org/10.1016/j.cub.2013.04.032
